1,720,969 research outputs found
BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death- involving diseases, and for modulation of cell survival and/or death.
No full textThe present invention provides BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for modulation of cell survival and/or death, in particular in leukemias, other neoplasias and apoptosis-involving diseases
BAG3 ANTIBODIES TO BE USED IN RESEARCH, DIAGNOSTICS AND THERAPY FOR CELL DEATH- INVOLVING DISEASES
No full textThe present invention provides BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for modulation of cell survival and/or death, in particular in leukemias, other neoplasias and apoptosis-involving diseases. More particularly the invention refers to the use of specific antisense-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemias, other neoplasias and cell death- involving diseases
Anticorpi BAG3 da utilizzare nella ricerca, nella diagnostica e nella terapia di malattie che comportano la morte cellulare.
No full textThe present invention provides BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for modulation of cell survival and/or death, in particular in leukemias, other neoplasias and apoptosis-involving diseases. More particularly the invention refers to the use of specific antisense~-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemias, other neoplasias and cell death- involving diseases
Regulation Zirf1 and basal SP1 trascription factor MRE-binding activity by transition metals.
No full textIsolamento e caratterizzazione di geni regolati dal rame e/o dal ferro nell'intestino del ratto
No full textIsolamento e caratterizzazione di geni regolati dal rame e/o dal ferro nell'intestino di ratto.
No full text
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Cloning and characterization of differentially expressed genes in dietary copper and iron depleted rat intestine
No full text- …
